These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6303060)

  • 1. The use of cefotaxime in pneumology.
    Grassi C; Colombo ML; Peona V
    Acta Med Port; 1983 Feb; 4(2):87-90. PubMed ID: 6303060
    [No Abstract]   [Full Text] [Related]  

  • 2. Cefotaxime in the treatment of lower respiratory tract infections.
    Beumer HM; Veldkamp J; Deleers L
    Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):605-10. PubMed ID: 6321367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical experience in the treatment of bacterial bronchopneumopathy with cefotaxime].
    Montanari S; Roca A; Pasqua F; Gramiccioni E
    Clin Ter; 1983 Apr; 105(2):119-24. PubMed ID: 6305552
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic efficacy and tolerability of cefotaxime--a study of acute respiratory infections in chronic lung conditions.
    Shah SP; Mehta AP; Shetty SR; Mahashur AA; Kamat SR
    J Postgrad Med; 1988 Jan; 34(1):15-20. PubMed ID: 3385652
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ambulatory anti-infective therapy. Multicentric studies with cefotaxime treatment of 12,181 patients].
    Pozzi E; Luisetti M; Peona V; Colombo ML
    G Ital Chemioter; 1982; 29(1):21-38. PubMed ID: 6309598
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparison between cefoperazone and cefotaxime in the treatment of infections of the lower respiratory tract].
    Fantoni U; Ruffilli MP; Ecari U
    Clin Ter; 1987 May; 121(3):209-12. PubMed ID: 2956011
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of cefotiam in the treatment of bacterial infections].
    Mussini C; Zanni G; Braglia MP
    Clin Ter; 1984 Dec; 111(5):401-9. PubMed ID: 6097395
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of the clinical activity of cefotiam (SCE 963). Multicentric study in 7 centers].
    Bryskier A; Humbert G; Borsa F; Bertrand A; Janbon F; Lafaix C; Beucler A; Veyssier P; Dusehu E; Modai J
    Pathol Biol (Paris); 1983 May; 31(5):328-35. PubMed ID: 6312392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ampicillin/sulbactam compared with cefotaxime in the treatment of lower respiratory tract infections of bacterial etiology.
    Jauregui L; Minns P; Hageage G
    Adv Ther; 1995; 12(1):62-71. PubMed ID: 10150322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical experience with a ampicillin-dicloxacillin combination in pneumology].
    Loianno R
    Clin Ter; 1977 Jul; 82(2):127-37. PubMed ID: 902467
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ceftizoxime in the treatment of urinary tract and respiratory infections in liver disease patients].
    Esposito S; Galante D; Barba D
    G Ital Chemioter; 1985; 32(2):361-5. PubMed ID: 3869114
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use in pneumology of a new antibiotic: kanendomycin].
    Giura R; Rossini G
    G Ital Chemioter; 1977; 24(1-2):11-4. PubMed ID: 615752
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ceftizoxime in the treatment of infective pathology in the elderly].
    Garotta F; Magni O; Meinardi G
    Boll Chim Farm; 1986 Dec; 125(12):127S-131S. PubMed ID: 3473994
    [No Abstract]   [Full Text] [Related]  

  • 14. [Aerosol therapy in pneumological practice, with the exception of tuberculosis].
    Unteanu G; Basacopol A
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1982; 31(4):375-8. PubMed ID: 6304855
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of cefotaxime in the treatment of infections associated with hematologic diseases].
    Kaneko H; Masaki T; Yamaguchi R; Takahashi N; Umeda M; Shirai T
    Jpn J Antibiot; 1983 Sep; 36(9):2502-14. PubMed ID: 6317914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefotaxime in the management of acute lower respiratory tract infection.
    Keelan P; Hone R; Martin L; Callaghan B; Harty M
    Ir Med J; 1982 May; 75(5 Suppl):6-7. PubMed ID: 6284676
    [No Abstract]   [Full Text] [Related]  

  • 17. [Respiratory infections in chronic bronchopneumopathies: treatment with ceftizoxime].
    Foddai GA; Pisano PL; Cardia P; Mereu S; Ligia GP; Farris A; Falqui AM; Pau LA
    G Ital Chemioter; 1984; 31(3):238-41. PubMed ID: 6100179
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evaluation of the effectiveness of ceftizoxime in the treatment of respiratory tract infections].
    Gialdroni Grassi G; Manara G; Mangiarotti P; Navone A
    G Ital Chemioter; 1982; 29(1):49-54. PubMed ID: 6309599
    [No Abstract]   [Full Text] [Related]  

  • 19. Cefotaxime: efficacy and tolerance in lower respiratory tract infections caused by gram-positive cocci.
    Lode H; Glatzel PD
    Infection; 1985; 13 Suppl 1():S25-7. PubMed ID: 4055050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Penetration of cefotaxime into bronchial secretions].
    Bergogne-Berezin E; Morel C; Pierre J; Monrocq N; Dournovo P; Benard Y
    Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):501-5. PubMed ID: 6289226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.